MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine receptor"

  • 2017 International Congress

    DaTscan in clinical evaluation of Multiple System Atrophy

    P. Khemani, S. Vernino (Dallas, TX, USA)

    Objective: To explore accuracy of DaTscanTM Ioflupane I123 Injection (DaTscan) in a multiple system atrophy (MSA) cohort  Background: There are isolated cases of normal DaTscan in neuropathologically confirmed MSA-cerebellar subtype (MSA-C)…
  • 2017 International Congress

    99mTc-TRODAT-1 SPECT imaging in early and late onset Parkinson’s disease.

    A. Ghabeli Juibary, V.R. Dabbagh Kakhki, P. Sasannejad, R. Sadeghi, K. Sadri, M. Sabour, H. Alizadeh (Mashhad, Islamic Republic of Iran)

    Objective: In this study we tried to determine  the TRODAT SPECT findings in EOPD  as compared to LOPD. Background: 99mTc-TRODAT-1, which binds to the dopamine…
  • 2017 International Congress

    Clinical Utility of Optimized Parameters for a Quantitative Analysis of 123I-ioflupane SPECT (DaTscan) Images

    G. Zubal, S. Tinaz, C. Chow, H. Blumenfeld, E. Louis (New Haven, CT, USA)

    Objective: Validate an automated analysis of DaTscan SPECT images on a representative cohort of patients for discriminating between Parkinson's Disease (PD) versus non-PD. Background: Quantitation…
  • 2017 International Congress

    Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease – on behalf of Critical Path for Parkinson’s (CPP) Consortium

    D. Stephenson, J. Cedarbaum, J. Eberling, M. Facheris, D. Grosset, M. Gordon, D. Hill, S. Imam, V. Kern, G. Klein, D. Matthews, P. Muglia, A. Roach, K. Romero, D. Russell, J. Seibyl, L. Slieker, E. Somer, C. Sur, Z. Xie, K. Marek (Tucson, AZ, USA)

    Objective: A key goal of the Critical Path for Parkinson’s Consortium (CPP) is to qualify, with regulatory agencies, drug development tools for use in PD…
  • 2016 International Congress

    Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model

    S. Li, Y. Wang, W. Liu, D. Lv, C. Liu (Suzhou, People's Republic of China)

    Objective: We aimed to study the effect of levodopa on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • 2016 International Congress

    Dopamine D3 receptor Ser9Gly variant is a risk factor for impulse control disorders in Parkinson’s disease

    A. Kishore, S. Krishnamoorthy, R. Rajan, S. Sarma, M. Banerjee (Trivandrum, India)

    Objective: To test if the allelic variants of dopamine (DRD3), glutamate (GRIN2B) and serotonin (HTR2A) receptors are risk factors for ipulse control disorders (ICD) in…
  • 2016 International Congress

    Dissecting the molecular mechanisms of Fyn-mediated levodopa induced dyskinesias

    M.P. Bordone, M.A. Bernardi, A. Damianich, S. Sanz-Blasco, G. Gómez, I.R.E. Taravini, M.E. Avale, O.S. Gershanik, J.E. Ferrario (Buenos Aires, Argentina)

    Objective: To investigate the crosstalk between D1 receptor (D1R) and the signaling of Fyn protein kinase in a mice model of levodopa (L-DOPA) induced dyskinesias…
  • 2016 International Congress

    The impact of levodopa and apomorphine on beta- and gamma-oscillations in cortico-basal ganglia circuits in experimental parkinsonism

    J. Kühn, J.K. Haumesser, P.J. Magill, A.A. Kühn, V.V. Nikulin, C. van Riesen (Berlin, Germany)

    Objective: To clarify the role of pathologic oscillations in Parkinson's disease (PD) we recorded local field potentials (LFPs) in cortico-basal ganglia circuits of Parkinsonian and…
  • 2016 International Congress

    PET examination of the monoamine transporter with 11C-beta-CIT

    M. Tábuas-Pereira, F. Oliveira, A. Moreira, M. Sousa, F. Moreira, C. Januário, A. Abrunhosa, M. Castelo-Branco (Coimbra, Portugal)

    Objective: To investigate the utility of 11C-β-CIT PET scan on Parkinson's disease diagnosis. Background: The monoamine reuptake sites transport dopamine, noradrenaline and serotonin from the…
  • 2016 International Congress

    Safety and efficacy of pardoprunox for patients with Parkinson’s disease: A meta-analysis

    N. Elsagheer, H. Ahmed, A. Attia, K. Awad, E. Ezzat, M. Abd Elaleem Aziz, A. Negida (Beni Suef, Egypt)

    Objective: The aim of this meta-analysis is to synthesize evidence from published randomized controlled trials (RCTs) about the safety and efficacy of Pardoprunox for Patients…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley